Uncovering NOTCH1 as a Promising Target in the Treatment of <i>MLL</i>-Rearranged Leukemia
<i>MLL</i> rearrangement (<i>MLL</i>r) is responsible for the development of acute leukemias with poor outcomes. Therefore, new therapeutic approaches are urgently needed. The NOTCH1 pathway plays a critical role in the pathogenesis of many cancers including acute leukemia. U...
Main Authors: | Jacqueline Fischer, Estelle Erkner, Rahel Fitzel, Pia Radszuweit, Hildegard Keppeler, Fulya Korkmaz, Giovanni Roti, Claudia Lengerke, Dominik Schneidawind, Corina Schneidawind |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/19/14466 |
Similar Items
-
Targeting MYC in combination with epigenetic regulators induces synergistic anti-leukemic effects in MLLr leukemia and simultaneously improves immunity
by: Rahel Fitzel, et al.
Published: (2023-07-01) -
MAT2A as Key Regulator and Therapeutic Target in <i>MLL</i>r Leukemogenesis
by: Kathy-Ann Secker, et al.
Published: (2020-05-01) -
Rewiring the Epigenetic Networks in MLL-Rearranged Leukemias: Epigenetic Dysregulation and Pharmacological Interventions
by: Anthony K. N. Chan, et al.
Published: (2019-05-01) -
MLL leukemia-associated rearrangements in peripheral blood lymphocytes from healthy individuals
by: María Sol Brassesco, et al.
Published: (2009-01-01) -
Only Hematopoietic Stem and Progenitor Cells from Cord Blood Are Susceptible to Malignant Transformation by <i>MLL-AF4</i> Translocations
by: Kathy-Ann Secker, et al.
Published: (2020-06-01)